Viridian Therapeutics, Inc. announced on September 8, 2023, Kristian Humer, the Chief Financial Officer of the company resigned, effective September 12, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.11 USD | -0.41% | -9.96% | -44.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.40% | 773M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- VRDN Stock
- News Viridian Therapeutics, Inc.
- Viridian Therapeutics, Inc. Announces Resignation of Kristian Humer as Chief Financial Officer